Glucagon-Like Peptide-1 Receptor Agonists and Major Adverse Cardiovascular Events in Patients With and Without Diabetes: A Meta-Analysis of Randomized-Controlled Trials.
Alireza HosseinpourAayushi SoodJahangir KamalpourEhsan ZandiSeyedAbbas PakmehrHamidreza HosseinpourAkshit SoodAnkit AgrawalRahul GuptaPublished in: Clinical cardiology (2024)
The findings of this meta-analysis indicated that patients who are overweight/obese but do not have diabetes have a comparable reduction in the risk of adverse cardiovascular events as those with diabetes. These results need to be confirmed further by large-scale randomized trials in the future.
Keyphrases
- cardiovascular events
- cardiovascular disease
- type diabetes
- coronary artery disease
- systematic review
- glycemic control
- end stage renal disease
- weight loss
- newly diagnosed
- ejection fraction
- chronic kidney disease
- metabolic syndrome
- adipose tissue
- physical activity
- peritoneal dialysis
- meta analyses
- randomized controlled trial
- emergency department
- skeletal muscle
- adverse drug
- patient reported outcomes